HIV/AIDS Therapy

WHO removes three Indian HIV drugs from approved list

Published in Medical Letter on the CDC and FDA, August 29th, 2004

The U.N. health agency has removed three Indian-made generic versions of antiretroviral drugs from its list of approved HIV medicines, saying it's uncertain they are biologically the same as the patented drugs.

The generic drugs, which are manufactured by India's Ranbaxy Laboratories, will be kept off the World Health Organization's list of approved HIV treatments until the company can submit evidence of new tests that prove the drugs are biologically equivalent to the original medicines, the agency said in a statement.

"This effectively means that the medicines may or may not offer the same therapeutic benefits as the originals on which they are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-08-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry